손닥터

2018/10/08 (4)

Synchronous Multiple Primary Lung Cancer (동시에 여러 곳에서 폐암이 생겨나?)

01_의학 상식/015_호흡기알레르기 친절한 lupin21kr 2018.10.08 13:46

Synchronous Multiple Primary Lung Cancer동시에 여러 곳에서 폐암이 생겨나?IntroductionSecond primary tumors - ‘Synchronous’ : Detected or resected simultaneously - ‘Metachronous’ : Detected some time after the primary lesionIncidence of synchronous lung cancers - ranges from 0.2% to 8% (3.5%-14% in autopsy studies) - Around 900,000 new multiple cancer cases globally (8% of 10,900,000) - Age 50-64 : 5~12% / Age..

만성폐쇄성 폐질환 (COPD) GOLD 가이드라인 2017

01_의학 상식/015_호흡기알레르기 친절한 lupin21kr 2018.10.08 13:40

만성폐쇄성 폐질환 (COPD) GOLD 가이드라인 2017GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE(GOLD) 2017COPD DefinitionChronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or..

소세포 폐암 (SCLC) 의 치료

01_의학 상식/015_호흡기알레르기 친절한 lupin21kr 2018.10.08 13:30

소세포 폐암 (SCLC) 의 치료Small-cell lung cancer (SCLC) - 13–15% of newly diagnosed lung cancer per year. - Most patients present with extensive stage disease --> expected survival : 2~4 months without Tx.Five year survival rates - Limited-stage SCLC : 10–13% - Extensive-stage SCLC : 1–2%WHO classification - 2 types of SCLC : pure and combined - Up to 28% may present with combined SCLC histology SCLC는 년..

간경화 환자의 복수의 치료, 간성 흉수의 치료

01_의학 상식/016_소화기 친절한 lupin21kr 2018.10.08 00:57

복수의 치료, 간성 흉수의 치료 Treatment of Ascites, Hepatic hydrothorax Ascites 의 pathophysiology - 문맥압 상승 --> 국소 혈관 확장 물질 생성 증가 (주로 NO) --> Splanchnic arterial vasodilatation --> Effective arterial blood volume 의 저하 --> 교감신경계, RAAS 항진, ADH 증가 --> 신장에서의 Na 저류, 세포외액 증가 --> 복수, 부종, Hyponatremia 발생. Hepatic hydrothorax 란? Presence of a pleural effusion in a patient with cirrhosis - does not have other reasons ..

Copyright © 손닥터 All Rights Reserved

Designed by JB FACTORY